Chonghan Kim

Mr. Chonghan Kim

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 June 2024 in Vaccines
Verified
Journal Article
Open access
PDF file
JMJoon-Gyu Min
Joon-Gyu Min
GKGuk-Hyun Kim
Guk-Hyun Kim
CKChonghan Kim
Chonghan Kim
WKWooju Kwon
Wooju Kwon
HJHyun Do Jeong
Hyun Do Jeong
KKKwangil Kim
Kwangil Kim
Red seabream iridovirus (RSIV) is a major cause of marine fish mortality in Korea, with no effective vaccine available since its first occurrence in the 1990s. This study evaluated the efficacy of a formalin-killed vaccine against RSIV in rock bream under laboratory and field conditions. For the field trial, a total of 103,200 rock bream from two commercial marine cage-cultured farms in Southern Korea were vaccinated. Farm A vaccinated 31,100 fish in July 2020 and monitored them for 18 weeks, while farm B vaccinated 30,700 fish in August 2020 and monitored them for 12 weeks. At farm A, where there was no RSIV infection, the vaccine efficacy was assessed in the lab, showing a relative percentage of survival (RPS) ranging from 40% to 80%. At farm B, where natural RSIV infections occurred, cumulative mortality rates were 36.43% in the vaccinated group and 80.32% in the control group, resulting in an RPS of 54.67%. The RSIV-infectious status and neutralizing antibody titers in serum mirrored the cumulative mortality results. This study demonstrates that the formalin-killed vaccine effectively prevents RSIV in cage-cultured rock bream under both laboratory and field conditions.

16 December 2025 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
GPGyeong-Seo Park
Gyeong-Seo Park
HKHwan-Ju Kim
Hwan-Ju Kim
MCMyung A. Cho
Myung A. Cho
SKSeung-Chai Kim
Seung-Chai Kim
CJChang-Gi Jeong
Chang-Gi Jeong
BSByoung-Joo Seo
Byoung-Joo Seo
Introduction: Shiga toxin-producing Escherichia coli (STEC), particularly strains harboring Stx2e , are the primary cause of edema disease (ED) in swine, leading to acute mortality and economic loss. Despite the use of antimicrobials and autogenous vaccines, control remains inadequate due to high genetic variability and upregulated multidrug resistance (MDR). In Korea, field outbreaks persist in post-weaning pigs, underscoring the need for immunologically relevant vaccine candidates. This study aimed to characterize STEC isolates from 2014 to 2025 and identify representative strains for vaccine development through integrated molecular, phenotypic, and resistance profiling. Methods: A total of 184 STEC isolates were collected from clinical swine cases submitted between 2014 and 2025. Isolates were characterized via PCR-based virulence gene profiling, cytotoxicity assays using Vero cells, antimicrobial susceptibility testing, and Gompertz-modeled in vitro growth kinetics. Principal component analysis (PCA) and multivariate clustering were applied to assess phenotypic patterns. Two candidate vaccine strains were selected using an integrated scoring system incorporating virulence, cytotoxicity, metabolic fitness, and antimicrobial resistance profiles. Results: A total of 184 STEC isolates were recovered from swine diagnostic submissions across nine Korean provinces between 2014 and 2025. Genotypic analysis identified 29 virulence gene profiles, with Stx2e and F18 being predominant. Phenotypic assays revealed that Stx2e-only isolates exhibited superior growth kinetics and higher cytotoxicity than other genotypes. Antimicrobial susceptibility testing demonstrated widespread multidrug resistance, especially to sulfonamides, β -lactams, and aminoglycosides. Principal component analysis showed clustering based on toxin profiles and metabolic traits. No non-MDR isolates were observed, underscoring the high resistance burden. Two Stx2e-positive isolates with complementary F18 profiles, strong proliferation (>4.0 × 10 8 CFU/mL), and consistent cytotoxicity were selected as optimal vaccine candidates. Whole-genome sequencing confirmed their genetic stability and field relevance, supporting their advancement into vaccine development pipelines. Conclusion: This study provides a decade-long surveillance-based framework for rational STEC vaccine design in swine. Two Stx2e-positive strains were selected as representative immunogen candidates based on integrated genotypic and phenotypic criteria. These findings support the development of scalable, field-relevant vaccine platforms aimed at reducing antimicrobial use and controlling edema disease in Korean pig populations.

28 August 2024 in Pathogens
Verified
Journal Article
Open access
PDF file
GPGyeong-Seo Park
Gyeong-Seo Park
SLSomin Lee
Somin Lee
MJMin A Jeong
Min A Jeong
SLSo Young Lee
So Young Lee
DCDong-Geun Cho
Dong-Geun Cho
CKChonghan Kim
Chonghan Kim
Caseous lymphadenitis (CLA) is a chronic and subclinical bacterial disease of ruminants caused by Corynebacterium pseudotuberculosis (C. pseudotuberculosis) infection. Until 2014, there were no reports of CLA outbreaks in South Korea; however, the prevalence of CLA cases has steadily increased. In this study, we used recently obtained field isolates to develop the first inactivated CLA vaccine in South Korea and evaluated it in various animal models. The inactivated vaccine was evaluated for virulence and effectiveness. Mice were tested for virulence and immunization challenges, and guinea pigs and Korean Native Black Goats (KNBGs) evaluated various vaccine concentrations to determine the optimal dose and effectiveness. In the case of KNBGs, clinical symptoms were not observed after vaccination. In addition, CLA-specific IgG was detected at a significantly (p < 0.05) high level and was maintained. In histopathological evaluations, inflammation was predominantly observed in the prefemoral lymph nodes in the non-vaccinated+CHAL group. The genetic diversity of C. pseudotuberculosis, which has become widespread in South Korea, is less than 0.5% our vaccine is expected to prevent infection by a wide range of strains effectively. In summary, our CLA vaccine can potentially prevent CLA and foster the growth of South Korea’s domestic KNBG industry.

19 June 2025 in Vaccines
Verified
Journal Article
Open access
PDF file
GPGyeong-Seo Park
Gyeong-Seo Park
BSByoung-Joo Seo
Byoung-Joo Seo
WKWooju Kwon
Wooju Kwon
YSYEONG LEE SEOK
YEONG LEE SEOK
HLHyo Jeong Lee
Hyo Jeong Lee
CKChonghan Kim
Chonghan Kim
Background/Objectives: Porcine circovirus type 2d (PCV2d) is the predominant genotype associated with porcine circovirus-associated disease (PCVAD), leading to significant economic losses. In South Korea, current vaccine lot-release testing relies on a T/C-ratio-based guinea pig assay, which lacks scientific justification and methodological robustness. This study aimed to develop and validate a statistically defined in-house ELISA using rabbit-derived polyclonal antibodies against PCV2d for the standardized evaluation of immunogenicity. Methods: Polyclonal IgG was generated by immunizing a rabbit with inactivated PCV2d, and it was purified through Protein A chromatography. Guinea pigs (n = 18) were immunized with IMMUNIS® DMVac, an inactivated PCV2d vaccine candidate developed by WOOGENE B&G, at different doses. In-house ELISA parameters were optimized (antigen coating, blocking agent, and substrate incubation), and analytical performance was evaluated by ROC, linearity, reproducibility, and specificity. Sera from guinea pigs and pigs were analyzed under validated conditions. Results: The optimal performance was achieved using 105 genomic copies/mL of the antigen coating and a 5% BSA blocking agent. The assay showed strong diagnostic accuracy (AUC = 0.97), reproducibility (CVs < 5%), and linearity (R2 = 0.9890). Specificity tests with PCV2a, PCV2b, and PRRSV showed minimal cross-reactivity (<7%). The cross-species comparison revealed a positive correlation (R2 = 0.1815) and acceptable agreement (bias = −0.21) between guinea pig and porcine sera. The validated cut-off (S/P = 0.4) enabled accurate classification across both species and aligned well with commercial kits. Conclusions: The in-house ELISA offers a robust, reproducible, and scientifically validated platform for immunogenicity verification, supporting its application in Korea’s national lot-release system. Homologous competition assays with PCV2d are planned to further confirm antigen specificity.

13 August 2026 in Vaccines
Verified
Journal Article
Open access
PDF file
GPGyeong-Seo Park
Gyeong-Seo Park
MPMinsung Park
Minsung Park
SLSomin Lee
Somin Lee
CKChonghan Kim
Chonghan Kim
BSByoung-Joo Seo
Byoung-Joo Seo
Bovine neonatal diarrhea (BND) is a leading cause of morbidity and mortality in pre-weaned calves. Commercial maternal vaccines targeting bovine rotavirus (BRV), bovine coronavirus (BCoV), and enterotoxigenic Escherichia coli (ETEC) have been available for decades, yet field outbreaks continue in vaccinated herds. This review examined peer-reviewed literature published between January 2019 and March 2026, identified through a structured PubMed search supplemented by reference-list screening. For BRV, a field strain sharing its VP7 genotype with a vaccine component was not neutralized by vaccine-induced antiserum, indicating that genotype concordance does not predict serologic coverage. For BCoV, hemagglutinin-esterase variation and regional lineage divergence indicate surface-protein evolution, although data linking these changes to reduced efficacy are not available. For ETEC, adhesin diversity and antimicrobial resistance affect both vaccination strategy and case management. Maternal vaccination retains biological value, but field performance is constrained by colostral variability, incomplete passive transfer, and product-to-product immunogenic differences. For all three pathogens, antigenic divergence from vaccine strains is located at individual epitopes, receptor-binding domains, or adhesins rather than at the level of whole-pathogen identity. Subunit and multi-epitope antigen designs, for which proof-of-concept constructs have been reported, operate at this level, and their selection requires characterization of candidate antigens for efficacy, diversity, polymorphism, and cross-protective breadth. Such antigen improvements address the pathogen-side gap but not the passive-transfer and mucosal constraints. Functional surveillance to guide antigen updating, field trials that measure passive-transfer efficiency, and adjunctive strategies are identified as priorities for BND control.

2 September 2026 in Animals
Verified
Journal Article
Open access
PDF file
SCSo-Won Choi
So-Won Choi
YJYe-Jin Jeong
Ye-Jin Jeong
EBEun-Jin Baek
Eun-Jin Baek
WKWooju Kwon
Wooju Kwon
CKChonghan Kim
Chonghan Kim
KKKwangil Kim
Kwangil Kim
Infectious spleen and kidney necrosis virus (ISKNV), a member of the genus Megalocytivirus, threatens ornamental and farmed aquaculture because of its broad host range and environmental persistence. This study investigated ISKNV infection dynamics and stage-dependent horizontal transmission in angelfish (Pterophyllum scalare). Immersion challenge experiments demonstrated that angelfish were highly susceptible to ISKNV infection, with cumulative mortality reaching 95% at 106 TCID50/mL. The estimated LD50 and ID50 values indicated that infection occurred even at sublethal viral concentrations. Viral loads peaked at 7 days post-immersion and were positively correlated with the severity of histopathological lesions in the spleen and kidney, including multifocal necrosis and enlarged basophilic cells. To assess horizontal transmission, naive fish were cohabited with infected donors for 24 h at different infection stages. These findings indicate that ISKNV transmission can occur following short-term cohabitation and that transmission outcomes may vary according to the infection stage of donor fish under the experimental conditions examined, providing insights into ISKNV transmission dynamics and the potential implications for disease management in the ornamental fish industry.